Study Stopped
This was inadvertently entered in the system and is not a clinical trial.
Quantitative Genioglossal Muscle Strength in Obstructive Sleep Apnea (OSAS)
EatonOSAS
1 other identifier
observational
13
1 country
1
Brief Summary
Quantitative Genioglossal muscle strength in Obstructive Sleep Apnea (OSAS) defined in the clinical spectrum of subjects with Snoring Disturbance, Oral Appliance Therapy Responsive, and CPAP Responsive
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 24, 2016
CompletedFirst Posted
Study publicly available on registry
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedJanuary 8, 2024
January 1, 2024
1.1 years
February 24, 2016
January 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Genioglossal Strength
quantitative measurement of tongue strength
single clinic visit
Study Arms (2)
OSAS subjects
CPAP Referral OSAS
Risk-Free subjects
paired normal control subjects
Eligibility Criteria
This initial pilot investigation will screen up to 70 individuals to obtain the necessary enrollment of 22 subjects per group from Stage Three: CPAP Referral OSAS; and paired normal control subjects
You may qualify if:
- Age 20-40 years inclusive BMI 18-25 Non-smoking history and no current use for a minimum of 6 months No smokeless tobacco products (including e-cigarettes) for a minimum of 6 months No sleep snoring reported by subject and by bedroom "companion" Self-described as active/athletic (i.e. regular hikes, walks, jogging, running, active Sports, such as volleyball, soccer, etc.) Self-described as healthy, with no known disease or recent illness Self-completed Epworth Sleepiness Scale of \<6 (Johns, MW, A new method for Measuring daytime sleepiness: the Epworth Sleepiness Scale; SLEEP 14:450-5, 1991). Physical Examination Mallampati Score of Class 1 (Nuckton, TJ, et al: Physical
- Examination: Mallampati Score as an Independent Predictor of OSAS; SLEEP 29:
- , 2006).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Translational Science Center
Albuquerque, New Mexico, 87131, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philip Eaton, MD
University of New Mexico
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2016
First Posted
March 1, 2016
Study Start
February 1, 2016
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
January 8, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share